| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |